News Events
March 22, 2007
Escape CEO Dr. Hantash to present at Annual Stem Cell Research & Therapeutics Conference.
Escape Therapeutics CEO Dr. Basil M. Hantash, MD, PhD to present his research findings on 1) Xenogenic transplantation of human adipose-derived mesenchymal stem cells, 2) Osteogenic differentiation of bone-marrow derived mesenchymal stem cells, and 3) Characterization of a self-assembling oligopeptide for skin engineering at the 2007 Annual Stem Cell Research & Therapeutics Conference (GTCbio) held in San Diego, CA.